Etiopathogenesis of Chronic Complications of Diabetes Mellitus

Overview

Central Etiology: Glucotoxicity (Persistent Hyperglycemia)

Four Core Mechanisms of Hyperglycemic Tissue Damage

1. Advanced Glycation End Products (AGEs)

• AGEs bind to a specific receptor called RAGE (receptor for AGEs), expressed on inflammatory cells (macrophages, T cells), endothelium, and vascular smooth muscle.
• Endothelium-specific overexpression of RAGE in diabetic mice accelerates large vessel injury and microangiopathy; RAGE-null mice show attenuation of these features.
• AGEs also directly cross-link extracellular matrix proteins (collagen, elastin), leading to vascular stiffness and basement membrane thickening; LDL gets trapped in AGE-modified large vessel walls (accelerating atherosclerosis), and albumin is trapped in capillary walls (contributing to microangiopathy).

• Release of TGF-β - deposition of excess basement membrane material
• Release of VEGF - neovascularization in diabetic retinopathy
• Generation of reactive oxygen species (ROS) in endothelial cells
• Increased procoagulant activity on endothelial cells and macrophages
• Enhanced proliferation of vascular smooth muscle cells and extracellular matrix synthesis

2. Activation of Protein Kinase C (PKC)

• Production of VEGF (neovascularization in retinopathy)
• Production of TGF-β (fibrogenesis, increased extracellular matrix)
• Production of PAI-1 (plasminogen activator inhibitor-1) - procoagulant state
• Enhanced angiogenesis, vasoconstriction, vascular permeability, cytokine activation

3. Oxidative Stress and Polyol Pathway Disturbances

• This reaction consumes NADPH as a cofactor.
• NADPH is also required by glutathione reductase to regenerate reduced glutathione (GSH), a key cellular antioxidant.
• Sustained hyperglycemia depletes intracellular NADPH, compromises GSH regeneration, and increases cellular susceptibility to oxidative stress.
• Sorbitol accumulation in the lens contributes to cataract formation.

4. Hexosamine Pathway Activation

• Upregulation of TGF-α and TGF-β1
• Upregulation of PAI-1
• Dysregulation of endothelial nitric oxide synthase (eNOS)
• Resulting in insulin resistance and vascular complications

Morphology of Chronic Complications

Pancreas

• T1D: Reduction in number/size of islets; insulitis (leukocytic - predominantly T lymphocyte - infiltration of islets)
• T2D: Subtle islet mass reduction; amyloid deposition (islet amyloid polypeptide/amylin) within islets, beginning around capillaries and eventually obliterating islets; fibrosis may also be present
• Nondiabetic newborns of diabetic mothers: islet hyperplasia in response to maternal hyperglycemia

Diabetic Macrovascular Disease

• Accelerated atherosclerosis involving the aorta and large/medium-sized arteries (morphologically indistinguishable from non-diabetic atherosclerosis)
• Myocardial infarction - most common cause of death in diabetes (2-4x higher coronary risk)
• Gangrene of lower extremities - ~100x more common than in the general population
• Cerebrovascular accidents
• Hypertension (present in ~75% of T2D) and diabetic dyslipidemia potentiate cardiovascular risk

Diabetic Microangiopathy

• Skin, skeletal muscle, retina, renal glomeruli, renal medulla
• Also in nonvascular structures: renal tubules, Bowman capsule, peripheral nerves, placenta

Specific Organ Complications

Diabetic Nephropathy

• Leading cause of end-stage renal disease (ESRD); second only to MI as cause of death in diabetes
• Affects ~30-40% of all diabetic patients
• Earliest manifestation: microalbuminuria (30-300 mg/day); progresses to macroalbuminuria (>300 mg/day) with hypertension
• Three major lesions:
  1. Glomerular lesions: capillary basement membrane (GBM) thickening, diffuse mesangial sclerosis (most common), nodular glomerulosclerosis (Kimmelstiel-Wilson nodules) - pathognomonic but not the most common lesion
  2. Renal vascular lesions: arteriolosclerosis of both afferent and efferent arterioles (efferent arteriolar hyalinosis is virtually pathognomonic of diabetes)
  3. Pyelonephritis: including necrotizing papillitis (renal papillary necrosis)
• Ethnic susceptibility: Native Americans, Hispanics, and African Americans have higher risk of ESRD

Diabetic Retinopathy

• Eventually affects >50-80% of patients with long-standing diabetes; leading cause of adult blindness in the United States
• Pathogenesis: Loss of retinal pericytes (supporting cells), basement membrane thickening, altered retinal blood flow; damaged capillaries leak protein, RBCs, and lipids causing retinal edema; chronic hypoxia from capillary occlusion promotes VEGF-driven neovascularization (new abnormal vessels prone to rupture)
• Classification:
  • Nonproliferative (background) retinopathy (NPDR): microaneurysms, intraretinal hemorrhages (blot/flame), hard exudates (lipid deposits), cotton-wool spots (soft exudates from ischemia), venous beading, IRMA (intraretinal microvascular abnormalities)
  • Proliferative diabetic retinopathy (PDR): neovascularization, pre-retinal/vitreous hemorrhage, traction retinal detachment, potential blindness
  • Diabetic macular edema: can occur at any stage; retinal thickening/hard exudates involving the macula

Diabetic Neuropathy

• Clinical peripheral neuropathy affects ~50% of all diabetic patients, and up to 80% of those with disease >15 years
• Three compartments are affected:
  • Peripheral sensorimotor neuropathy: "stocking-glove" sensory loss, pain, paresthesias; predisposes to Charcot joint (neuropathic arthropathy) and diabetic foot ulcers
  • Autonomic neuropathy: postural hypotension, gastroparesis, impotence, bladder dysfunction, diarrhea/constipation
  • Mononeuropathy (cranial or peripheral): acute onset, e.g., CN III or CN VI palsy causing diplopia

Infections (Increased Susceptibility)

• Impaired neutrophil function (chemotaxis, phagocytosis, killing)
• Poor tissue perfusion
• Hyperglycemic environment favoring microbial growth

Summary: Pathogenesis in a Unifying Framework

Persistent Hyperglycemia (Glucotoxicity)
          |
    ┌─────┴────────────────────────────┐
    │                                  │
 AGE Formation              PKC Activation (via DAG)
  + RAGE signaling         Polyol pathway (sorbitol/NADPH depletion)
  + Cross-linking           Hexosamine pathway activation
    │                                  │
    └──────────── Oxidative Stress ────┘
                       |
        ┌──────────────┼──────────────┐
        │              │              │
   Endothelial      Basement       Vascular
   Dysfunction      Membrane       Smooth Muscle
   (leaky vessels)  Thickening     Proliferation
        │              │              │
   ┌────┴───────────────┴──────────────┴────┐
   │           END-ORGAN DAMAGE             │
   ├─ Macrovascular: Atherosclerosis        │
   │  (MI, stroke, peripheral vascular)     │
   ├─ Microangiopathy: Nephropathy          │
   │  Retinopathy, Neuropathy               │
   └─────────────────────────────────────────┘

• Robbins & Kumar Basic Pathology, p. 749-750
• Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 1023-1026
• Goldman-Cecil Medicine, Chapter 210